Switching On Safety: RNA Logic Devices for Advanced Therapeutics
Smart RNA logic devices that bring precision, control, and confidence to gene and cell therapies.
About Us
Innovation with Built-In Control.
DaedalLogix Biosystems develops modular RNA logic devices designed to make gene, cell, and cancer therapies safer and more predictable. Our technology provides a built-in layer of control, allowing therapies to activate only in the right cells, at the right time, and at the right level.
Inspired by the story of Daedalus, which teaches the importance of balancing ambition with control, we aim to support the next generation of life-changing treatments with technology that is both innovative and safe.
The Challenge
The Hidden Risk in Gene and Cell Therapies
Gene and cancer therapies have the potential to transform healthcare, yet many current approaches lack precise control over when and where therapeutic genes become active.
Unintended or off-target expression can lead to significant safety risks, unwanted side effects, and reduced confidence during preclinical and clinical development.
These challenges limit the impact of otherwise powerful treatments and slow the path to clinical success.
Our Approach
Built-in Control for Safer Therapies
Our RNA logic devices add a new layer of precision, safety, and adaptability to advanced therapeutic development.
Precise Activation
Our RNA logic devices ensure therapeutic genes activate only in the intended cells and tissues.
Modular RNA Design
A programmable, flexible system that can be adapted to suit a wide range of therapeutic approaches.
Safety On and Off Switches
Drug-inducible control allows therapies to be switched on or off as required for improved safety.
Compatible Across Therapies
A scalable platform designed to integrate seamlessly with gene, cell, and cancer therapy pipelines.
Meet the Team Behind DaedalLogix
Adam Mol, PhD
Entrepreneurial Lead
University of Edinburgh
Professor Susan Rosser
Principal Scientific Advisor
University of Edinburgh
Barbara Blaney, PhD
Technology Transfer Officer
Edinburgh Innovations
Interested in Safer, Smarter Therapies?
We’re speaking with biotech teams, CROs, and researchers who want to improve control, precision, and safety in gene and cell therapies.
If you’re exploring new tools to reduce off-target effects, accelerate development, or tailor expression more precisely, we’d love to connect.
Leave your details and we’ll get back to you for an informal conversation.